{ "meta": { "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.", "terms": "https://open.fda.gov/terms/", "license": "https://open.fda.gov/license/", "last_updated": "2026-04-28", "results": { "skip": 0, "limit": 1, "total": 123113 } }, "results": [ { "safetyreportversion": "1", "safetyreportid": "10003687", "primarysourcecountry": "US", "occurcountry": "US", "transmissiondateformat": "102", "transmissiondate": "20141002", "reporttype": "1", "serious": "2", "receivedateformat": "102", "receivedate": "20140312", "receiptdateformat": "102", "receiptdate": "20140312", "fulfillexpeditecriteria": "2", "companynumb": "US-ABBVIE-13P-163-1084327-00", "duplicate": "1", "reportduplicate": { "duplicatesource": "ABBVIE", "duplicatenumb": "US-ABBVIE-13P-163-1084327-00" }, "primarysource": { "reportercountry": "US", "qualification": "5" }, "sender": { "sendertype": "2", "senderorganization": "FDA-Public Use" }, "receiver": { "receivertype": "6", "receiverorganization": "FDA" }, "patient": { "patientonsetage": "51", "patientonsetageunit": "801", "patientsex": "1", "reaction": [ { "reactionmeddraversionpt": "17.0", "reactionmeddrapt": "Somnolence", "reactionoutcome": "1" }, { "reactionmeddraversionpt": "17.0", "reactionmeddrapt": "Trismus", "reactionoutcome": "1" }, { "reactionmeddraversionpt": "17.0", "reactionmeddrapt": "Fatigue", "reactionoutcome": "6" } ], "drug": [ { "drugcharacterization": "1", "medicinalproduct": "DEPAKOTE", "drugbatchnumb": "UNKNOWN", "drugauthorizationnumb": "018723", "drugstructuredosagenumb": "500", "drugstructuredosageunit": "003", "drugseparatedosagenumb": "1", "drugintervaldosageunitnumb": "1", "drugintervaldosagedefinition": "804", "drugadministrationroute": "048", "drugindication": "BIPOLAR DISORDER", "drugstartdateformat": "610", "drugstartdate": "200801", "drugenddateformat": "102", "drugenddate": "20100402", "openfda": { "application_number": [ "NDA021168", "NDA018723", "NDA019680" ], "brand_name": [ "DEPAKOTE ER", "DEPAKOTE", "DEPAKOTE SPRINKLES" ], "generic_name": [ "DIVALPROEX SODIUM" ], "manufacturer_name": [ "AbbVie Inc." ], "product_ndc": [ "0074-7401", "0074-3826", "0074-7126", "0074-7402", "0074-7325", "0074-6212", "0074-6214", "0074-6215", "0074-7327", "0074-7326", "0074-6114" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DIVALPROEX SODIUM" ], "rxcui": [ "1099563", "1099565", "1099569", "1099571", "1099625", "1099626", "1099678", "1099679", "1099870", "1099871", "1099596", "1099598" ], "spl_id": [ "0ee65b66-ead3-44ef-911f-14965b067903", "7cc3a0b3-93f8-4825-88e1-bf6ddb0db23d", "d038b7e9-b014-4771-93be-90aeeaece03d" ], "spl_set_id": [ "0dc024ce-efc8-4690-7cb5-639c728fccac", "08a65cf4-7749-4ceb-6895-8f4805e2b01f", "4619aff4-0f80-444f-858d-42e4137aa809" ], "package_ndc": [ "0074-3826-13", "0074-3826-11", "0074-7401-13", "0074-7126-13", "0074-7126-53", "0074-7126-11", "0074-7126-72", "0074-7402-13", "0074-6212-13", "0074-6214-13", "0074-6214-53", "0074-6215-13", "0074-6215-53", "0074-7325-13", "0074-7327-13", "0074-7326-13", "0074-6114-13", "0074-6114-11" ], "unii": [ "644VL95AO6" ] } }, { "drugcharacterization": "1", "medicinalproduct": "DEPAKOTE", "drugbatchnumb": "UNKNOWN", "drugauthorizationnumb": "018723", "drugstructuredosagenumb": "250", "drugstructuredosageunit": "003", "drugseparatedosagenumb": "1", "drugintervaldosageunitnumb": "1", "drugintervaldosagedefinition": "804", "drugstartdateformat": "102", "drugstartdate": "20100403", "drugenddateformat": "102", "drugenddate": "20100415", "openfda": { "application_number": [ "NDA021168", "NDA018723", "NDA019680" ], "brand_name": [ "DEPAKOTE ER", "DEPAKOTE", "DEPAKOTE SPRINKLES" ], "generic_name": [ "DIVALPROEX SODIUM" ], "manufacturer_name": [ "AbbVie Inc." ], "product_ndc": [ "0074-7401", "0074-3826", "0074-7126", "0074-7402", "0074-7325", "0074-6212", "0074-6214", "0074-6215", "0074-7327", "0074-7326", "0074-6114" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DIVALPROEX SODIUM" ], "rxcui": [ "1099563", "1099565", "1099569", "1099571", "1099625", "1099626", "1099678", "1099679", "1099870", "1099871", "1099596", "1099598" ], "spl_id": [ "0ee65b66-ead3-44ef-911f-14965b067903", "7cc3a0b3-93f8-4825-88e1-bf6ddb0db23d", "d038b7e9-b014-4771-93be-90aeeaece03d" ], "spl_set_id": [ "0dc024ce-efc8-4690-7cb5-639c728fccac", "08a65cf4-7749-4ceb-6895-8f4805e2b01f", "4619aff4-0f80-444f-858d-42e4137aa809" ], "package_ndc": [ "0074-3826-13", "0074-3826-11", "0074-7401-13", "0074-7126-13", "0074-7126-53", "0074-7126-11", "0074-7126-72", "0074-7402-13", "0074-6212-13", "0074-6214-13", "0074-6214-53", "0074-6215-13", "0074-6215-53", "0074-7325-13", "0074-7327-13", "0074-7326-13", "0074-6114-13", "0074-6114-11" ], "unii": [ "644VL95AO6" ] } }, { "drugcharacterization": "1", "medicinalproduct": "DEPAKOTE", "drugbatchnumb": "UNKNOWN", "drugauthorizationnumb": "018723", "drugstructuredosagenumb": "750", "drugstructuredosageunit": "003", "drugseparatedosagenumb": "1", "drugintervaldosageunitnumb": "1", "drugintervaldosagedefinition": "804", "openfda": { "application_number": [ "NDA021168", "NDA018723", "NDA019680" ], "brand_name": [ "DEPAKOTE ER", "DEPAKOTE", "DEPAKOTE SPRINKLES" ], "generic_name": [ "DIVALPROEX SODIUM" ], "manufacturer_name": [ "AbbVie Inc." ], "product_ndc": [ "0074-7401", "0074-3826", "0074-7126", "0074-7402", "0074-7325", "0074-6212", "0074-6214", "0074-6215", "0074-7327", "0074-7326", "0074-6114" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DIVALPROEX SODIUM" ], "rxcui": [ "1099563", "1099565", "1099569", "1099571", "1099625", "1099626", "1099678", "1099679", "1099870", "1099871", "1099596", "1099598" ], "spl_id": [ "0ee65b66-ead3-44ef-911f-14965b067903", "7cc3a0b3-93f8-4825-88e1-bf6ddb0db23d", "d038b7e9-b014-4771-93be-90aeeaece03d" ], "spl_set_id": [ "0dc024ce-efc8-4690-7cb5-639c728fccac", "08a65cf4-7749-4ceb-6895-8f4805e2b01f", "4619aff4-0f80-444f-858d-42e4137aa809" ], "package_ndc": [ "0074-3826-13", "0074-3826-11", "0074-7401-13", "0074-7126-13", "0074-7126-53", "0074-7126-11", "0074-7126-72", "0074-7402-13", "0074-6212-13", "0074-6214-13", "0074-6214-53", "0074-6215-13", "0074-6215-53", "0074-7325-13", "0074-7327-13", "0074-7326-13", "0074-6114-13", "0074-6114-11" ], "unii": [ "644VL95AO6" ] } }, { "drugcharacterization": "1", "medicinalproduct": "LEXAPRO", "drugbatchnumb": "UNKNOWN", "drugstructuredosagenumb": "10", "drugstructuredosageunit": "003", "drugseparatedosagenumb": "1", "drugintervaldosageunitnumb": "1", "drugintervaldosagedefinition": "804", "drugdosageform": "TABLET", "drugadministrationroute": "048", "drugindication": "DEPRESSION", "drugstartdateformat": "610", "drugstartdate": "200806", "drugenddateformat": "610", "drugenddate": "201107", "openfda": { "application_number": [ "NDA021323" ], "brand_name": [ "LEXAPRO" ], "generic_name": [ "ESCITALOPRAM" ], "manufacturer_name": [ "Allergan, Inc." ], "product_ndc": [ "0456-2005", "0456-2010", "0456-2020", "0456-2101" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "ESCITALOPRAM OXALATE" ], "rxcui": [ "349332", "351249", "351250", "351285", "352272", "352273", "404408", "404420" ], "spl_id": [ "9ff46a66-0f97-4a78-9d18-ec576f63bae7" ], "spl_set_id": [ "13bb8267-1cab-43e5-acae-55a4d957630a" ], "package_ndc": [ "0456-2005-01", "0456-2010-01", "0456-2010-11", "0456-2010-63", "0456-2020-01", "0456-2020-11", "0456-2020-63", "0456-2101-08" ], "unii": [ "5U85DBW7LO" ] } }, { "drugcharacterization": "1", "medicinalproduct": "LEXAPRO", "drugbatchnumb": "UNKNOWN", "drugstructuredosagenumb": "20", "drugstructuredosageunit": "003", "drugseparatedosagenumb": "1", "drugintervaldosageunitnumb": "1", "drugintervaldosagedefinition": "804", "drugdosageform": "TABLET", "drugadministrationroute": "048", "drugindication": "OBSESSIVE-COMPULSIVE DISORDER", "drugstartdateformat": "610", "drugstartdate": "201107", "openfda": { "application_number": [ "NDA021323" ], "brand_name": [ "LEXAPRO" ], "generic_name": [ "ESCITALOPRAM" ], "manufacturer_name": [ "Allergan, Inc." ], "product_ndc": [ "0456-2005", "0456-2010", "0456-2020", "0456-2101" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "ESCITALOPRAM OXALATE" ], "rxcui": [ "349332", "351249", "351250", "351285", "352272", "352273", "404408", "404420" ], "spl_id": [ "9ff46a66-0f97-4a78-9d18-ec576f63bae7" ], "spl_set_id": [ "13bb8267-1cab-43e5-acae-55a4d957630a" ], "package_ndc": [ "0456-2005-01", "0456-2010-01", "0456-2010-11", "0456-2010-63", "0456-2020-01", "0456-2020-11", "0456-2020-63", "0456-2101-08" ], "unii": [ "5U85DBW7LO" ] } }, { "drugcharacterization": "1", "medicinalproduct": "LEXAPRO", "drugbatchnumb": "UNKNOWN", "drugstructuredosagenumb": "10", "drugstructuredosageunit": "003", "drugseparatedosagenumb": "1", "drugintervaldosageunitnumb": "1", "drugintervaldosagedefinition": "804", "drugdosageform": "TABLET", "drugadministrationroute": "048", "drugenddateformat": "610", "drugenddate": "201112", "openfda": { "application_number": [ "NDA021323" ], "brand_name": [ "LEXAPRO" ], "generic_name": [ "ESCITALOPRAM" ], "manufacturer_name": [ "Allergan, Inc." ], "product_ndc": [ "0456-2005", "0456-2010", "0456-2020", "0456-2101" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "ESCITALOPRAM OXALATE" ], "rxcui": [ "349332", "351249", "351250", "351285", "352272", "352273", "404408", "404420" ], "spl_id": [ "9ff46a66-0f97-4a78-9d18-ec576f63bae7" ], "spl_set_id": [ "13bb8267-1cab-43e5-acae-55a4d957630a" ], "package_ndc": [ "0456-2005-01", "0456-2010-01", "0456-2010-11", "0456-2010-63", "0456-2020-01", "0456-2020-11", "0456-2020-63", "0456-2101-08" ], "unii": [ "5U85DBW7LO" ] } }, { "drugcharacterization": "1", "medicinalproduct": "LEXAPRO", "drugbatchnumb": "UNKNOWN", "drugstructuredosagenumb": "10", "drugstructuredosageunit": "003", "drugseparatedosagenumb": "1", "drugintervaldosageunitnumb": "1", "drugintervaldosagedefinition": "804", "drugdosageform": "TABLET", "drugadministrationroute": "048", "drugenddateformat": "610", "drugenddate": "201204", "openfda": { "application_number": [ "NDA021323" ], "brand_name": [ "LEXAPRO" ], "generic_name": [ "ESCITALOPRAM" ], "manufacturer_name": [ "Allergan, Inc." ], "product_ndc": [ "0456-2005", "0456-2010", "0456-2020", "0456-2101" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "ESCITALOPRAM OXALATE" ], "rxcui": [ "349332", "351249", "351250", "351285", "352272", "352273", "404408", "404420" ], "spl_id": [ "9ff46a66-0f97-4a78-9d18-ec576f63bae7" ], "spl_set_id": [ "13bb8267-1cab-43e5-acae-55a4d957630a" ], "package_ndc": [ "0456-2005-01", "0456-2010-01", "0456-2010-11", "0456-2010-63", "0456-2020-01", "0456-2020-11", "0456-2020-63", "0456-2101-08" ], "unii": [ "5U85DBW7LO" ] } }, { "drugcharacterization": "1", "medicinalproduct": "SEROQUEL", "drugbatchnumb": "UNKNOWN", "drugstructuredosagenumb": "500", "drugstructuredosageunit": "003", "drugseparatedosagenumb": "1", "drugintervaldosageunitnumb": "1", "drugintervaldosagedefinition": "804", "drugadministrationroute": "048", "drugindication": "BIPOLAR DISORDER", "drugstartdateformat": "610", "drugstartdate": "200805", "drugenddateformat": "610", "drugenddate": "200908", "openfda": { "application_number": [ "NDA022047", "NDA020639" ], "brand_name": [ "SEROQUEL XR", "SEROQUEL" ], "generic_name": [ "QUETIAPINE" ], "manufacturer_name": [ "AstraZeneca Pharmaceuticals LP", "H2-Pharma, LLC" ], "product_ndc": [ "0310-0281", "0310-0282", "0310-0283", "0310-0284", "0310-0280", "61269-250", "61269-251", "61269-252", "61269-253", "61269-254", "61269-255", "0310-0271", "0310-0275", "0310-0278", "0310-0272", "0310-0274", "0310-0279", "61269-270", "61269-272", "61269-273", "61269-274", "61269-271" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "QUETIAPINE FUMARATE" ], "rxcui": [ "721791", "721793", "721794", "721795", "721796", "721797", "853201", "853202", "895670", "895671", "153638", "153639", "153640", "284509", "312743", "312744", "312745", "317174", "616483", "616485", "616487", "616489" ], "spl_id": [ "8e78eabf-6ff9-409b-ba1b-d9cb8d4f3fe0", "1fc7d584-a2f0-47f7-9506-5ecb2bfebb65", "aef69992-4a20-4d55-b85c-7c0799619ce6", "30d64c02-e070-43b8-9c96-3f7b112c5f7c" ], "spl_set_id": [ "473a3ac4-67f4-4782-baa9-7f9bdd8761f4", "8ae62aaf-f8c5-417f-baac-0098369ca322", "0584dda8-bc3c-48fe-1a90-79608f78e8a0", "ab959a35-d0ba-4f18-8f2e-6619d88b16e3" ], "package_ndc": [ "0310-0282-39", "0310-0282-94", "0310-0282-60", "0310-0283-39", "0310-0283-55", "0310-0283-60", "0310-0283-94", "0310-0284-39", "0310-0284-60", "0310-0284-94", "0310-0280-60", "0310-0280-39", "0310-0280-94", "0310-0281-39", "0310-0281-60", "61269-250-10", "61269-251-10", "61269-252-10", "61269-253-10", "61269-254-60", "61269-255-10", "0310-0275-10", "0310-0275-34", "0310-0275-39", "0310-0278-10", "0310-0278-34", "0310-0278-39", "0310-0271-10", "0310-0271-39", "0310-0272-10", "0310-0272-39", "0310-0274-60", "0310-0274-39", "0310-0279-10", "0310-0279-39", "61269-272-60", "61269-273-60", "61269-274-60", "61269-270-60", "61269-271-60" ], "unii": [ "2S3PL1B6UJ" ] } }, { "drugcharacterization": "1", "medicinalproduct": "SEROQUEL", "drugbatchnumb": "UNKNOWN", "drugstructuredosagenumb": "100", "drugstructuredosageunit": "003", "drugseparatedosagenumb": "1", "drugintervaldosageunitnumb": "1", "drugintervaldosagedefinition": "804", "drugadministrationroute": "048", "drugstartdateformat": "610", "drugstartdate": "200908", "drugenddateformat": "610", "drugenddate": "201002", "openfda": { "application_number": [ "NDA022047", "NDA020639" ], "brand_name": [ "SEROQUEL XR", "SEROQUEL" ], "generic_name": [ "QUETIAPINE" ], "manufacturer_name": [ "AstraZeneca Pharmaceuticals LP", "H2-Pharma, LLC" ], "product_ndc": [ "0310-0281", "0310-0282", "0310-0283", "0310-0284", "0310-0280", "61269-250", "61269-251", "61269-252", "61269-253", "61269-254", "61269-255", "0310-0271", "0310-0275", "0310-0278", "0310-0272", "0310-0274", "0310-0279", "61269-270", "61269-272", "61269-273", "61269-274", "61269-271" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "QUETIAPINE FUMARATE" ], "rxcui": [ "721791", "721793", "721794", "721795", "721796", "721797", "853201", "853202", "895670", "895671", "153638", "153639", "153640", "284509", "312743", "312744", "312745", "317174", "616483", "616485", "616487", "616489" ], "spl_id": [ "8e78eabf-6ff9-409b-ba1b-d9cb8d4f3fe0", "1fc7d584-a2f0-47f7-9506-5ecb2bfebb65", "aef69992-4a20-4d55-b85c-7c0799619ce6", "30d64c02-e070-43b8-9c96-3f7b112c5f7c" ], "spl_set_id": [ "473a3ac4-67f4-4782-baa9-7f9bdd8761f4", "8ae62aaf-f8c5-417f-baac-0098369ca322", "0584dda8-bc3c-48fe-1a90-79608f78e8a0", "ab959a35-d0ba-4f18-8f2e-6619d88b16e3" ], "package_ndc": [ "0310-0282-39", "0310-0282-94", "0310-0282-60", "0310-0283-39", "0310-0283-55", "0310-0283-60", "0310-0283-94", "0310-0284-39", "0310-0284-60", "0310-0284-94", "0310-0280-60", "0310-0280-39", "0310-0280-94", "0310-0281-39", "0310-0281-60", "61269-250-10", "61269-251-10", "61269-252-10", "61269-253-10", "61269-254-60", "61269-255-10", "0310-0275-10", "0310-0275-34", "0310-0275-39", "0310-0278-10", "0310-0278-34", "0310-0278-39", "0310-0271-10", "0310-0271-39", "0310-0272-10", "0310-0272-39", "0310-0274-60", "0310-0274-39", "0310-0279-10", "0310-0279-39", "61269-272-60", "61269-273-60", "61269-274-60", "61269-270-60", "61269-271-60" ], "unii": [ "2S3PL1B6UJ" ] } }, { "drugcharacterization": "1", "medicinalproduct": "SEROQUEL", "drugbatchnumb": "UNKNOWN", "drugstructuredosagenumb": "50", "drugstructuredosageunit": "003", "drugseparatedosagenumb": "1", "drugintervaldosageunitnumb": "1", "drugintervaldosagedefinition": "804", "drugadministrationroute": "048", "drugstartdateformat": "610", "drugstartdate": "201002", "drugenddateformat": "102", "drugenddate": "20100302", "openfda": { "application_number": [ "NDA022047", "NDA020639" ], "brand_name": [ "SEROQUEL XR", "SEROQUEL" ], "generic_name": [ "QUETIAPINE" ], "manufacturer_name": [ "AstraZeneca Pharmaceuticals LP", "H2-Pharma, LLC" ], "product_ndc": [ "0310-0281", "0310-0282", "0310-0283", "0310-0284", "0310-0280", "61269-250", "61269-251", "61269-252", "61269-253", "61269-254", "61269-255", "0310-0271", "0310-0275", "0310-0278", "0310-0272", "0310-0274", "0310-0279", "61269-270", "61269-272", "61269-273", "61269-274", "61269-271" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "QUETIAPINE FUMARATE" ], "rxcui": [ "721791", "721793", "721794", "721795", "721796", "721797", "853201", "853202", "895670", "895671", "153638", "153639", "153640", "284509", "312743", "312744", "312745", "317174", "616483", "616485", "616487", "616489" ], "spl_id": [ "8e78eabf-6ff9-409b-ba1b-d9cb8d4f3fe0", "1fc7d584-a2f0-47f7-9506-5ecb2bfebb65", "aef69992-4a20-4d55-b85c-7c0799619ce6", "30d64c02-e070-43b8-9c96-3f7b112c5f7c" ], "spl_set_id": [ "473a3ac4-67f4-4782-baa9-7f9bdd8761f4", "8ae62aaf-f8c5-417f-baac-0098369ca322", "0584dda8-bc3c-48fe-1a90-79608f78e8a0", "ab959a35-d0ba-4f18-8f2e-6619d88b16e3" ], "package_ndc": [ "0310-0282-39", "0310-0282-94", "0310-0282-60", "0310-0283-39", "0310-0283-55", "0310-0283-60", "0310-0283-94", "0310-0284-39", "0310-0284-60", "0310-0284-94", "0310-0280-60", "0310-0280-39", "0310-0280-94", "0310-0281-39", "0310-0281-60", "61269-250-10", "61269-251-10", "61269-252-10", "61269-253-10", "61269-254-60", "61269-255-10", "0310-0275-10", "0310-0275-34", "0310-0275-39", "0310-0278-10", "0310-0278-34", "0310-0278-39", "0310-0271-10", "0310-0271-39", "0310-0272-10", "0310-0272-39", "0310-0274-60", "0310-0274-39", "0310-0279-10", "0310-0279-39", "61269-272-60", "61269-273-60", "61269-274-60", "61269-270-60", "61269-271-60" ], "unii": [ "2S3PL1B6UJ" ] } }, { "drugcharacterization": "2", "medicinalproduct": "SYNTHROID", "drugstructuredosagenumb": "250", "drugstructuredosageunit": "004", "drugseparatedosagenumb": "1", "drugintervaldosageunitnumb": "1", "drugintervaldosagedefinition": "804", "drugdosageform": "TABLET", "drugadministrationroute": "048", "drugindication": "HYPOTHYROIDISM", "openfda": { "application_number": [ "NDA021402" ], "brand_name": [ "SYNTHROID" ], "generic_name": [ "LEVOTHYROXINE SODIUM" ], "manufacturer_name": [ "AbbVie Inc." ], "product_ndc": [ "0074-3727", "0074-4341", "0074-4552", "0074-5182", "0074-6594", "0074-6624", "0074-9296", "0074-7068", "0074-7069", "0074-7070", "0074-7148", "0074-7149" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "LEVOTHYROXINE SODIUM" ], "rxcui": [ "892246", "892251", "892255", "966158", "966171", "966185", "966191", "966201", "966205", "966218", "966220", "966221", "966222", "966224", "966225", "966247", "966248", "966249", "966250", "966251", "966253", "966270", "966271", "966282" ], "spl_id": [ "b85ab7fa-ba96-43cd-b736-44b3924e644c" ], "spl_set_id": [ "1e11ad30-1041-4520-10b0-8f9d30d30fcc" ], "package_ndc": [ "0074-4341-13", "0074-4341-90", "0074-4341-19", "0074-4341-72", "0074-4552-13", "0074-4552-90", "0074-4552-19", "0074-4552-11", "0074-4552-71", "0074-4552-72", "0074-5182-13", "0074-5182-90", "0074-5182-71", "0074-5182-19", "0074-5182-11", "0074-5182-72", "0074-6594-13", "0074-6594-90", "0074-6594-71", "0074-6594-19", "0074-6594-72", "0074-6624-13", "0074-6624-90", "0074-6624-19", "0074-6624-11", "0074-6624-71", "0074-6624-72", "0074-9296-13", "0074-9296-90", "0074-9296-19", "0074-9296-71", "0074-9296-72", "0074-7068-13", "0074-7068-90", "0074-7068-71", "0074-7068-19", "0074-7068-11", "0074-7068-72", "0074-3727-13", "0074-3727-90", "0074-3727-71", "0074-3727-19", "0074-3727-72", "0074-7069-90", "0074-7069-71", "0074-7069-19", "0074-7069-11", "0074-7069-72", "0074-7070-13", "0074-7070-90", "0074-7070-71", "0074-7070-19", "0074-7070-72", "0074-7148-90", "0074-7148-19", "0074-7148-71", "0074-7148-11", "0074-7148-72", "0074-7149-90", "0074-7149-19" ], "unii": [ "9J765S329G" ] } }, { "drugcharacterization": "2", "medicinalproduct": "CLOMIPRAMINE", "drugstructuredosagenumb": "100", "drugstructuredosageunit": "003", "drugseparatedosagenumb": "1", "drugintervaldosageunitnumb": "1", "drugintervaldosagedefinition": "804", "drugindication": "OBSESSIVE-COMPULSIVE DISORDER", "drugstartdateformat": "602", "drugstartdate": "2012" }, { "drugcharacterization": "2", "medicinalproduct": "METOPROLOL", "drugstructuredosagenumb": "25", "drugstructuredosageunit": "003", "drugseparatedosagenumb": "1", "drugintervaldosageunitnumb": "1", "drugintervaldosagedefinition": "804", "drugindication": "HYPERTENSION", "openfda": { "application_number": [ "ANDA078950", "ANDA091045", "ANDA202871" ], "brand_name": [ "METOPROLOL", "METOPROLOL TARTRATE" ], "generic_name": [ "METOPROLOL TARTRATE", "METOPROLOL" ], "manufacturer_name": [ "Baxter Healthcare Corporation", "Fresenius Kabi USA, LLC", "Alembic Pharmaceuticals Inc.", "Alembic Pharmaceuticals Limited" ], "product_ndc": [ "36000-033", "63323-660", "62332-112", "62332-113", "62332-114", "65219-665", "46708-290", "46708-291", "46708-292" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "INTRAVENOUS", "ORAL" ], "substance_name": [ "METOPROLOL TARTRATE" ], "rxcui": [ "866508", "866511", "866514", "866924" ], "spl_id": [ "5d975af3-d078-4130-9448-ed77123f1aac", "4066607a-15cb-42ac-999e-5254907dda5a", "c7738f42-299e-4bea-af50-778e069352f0", "ccb1a15e-c943-4042-ae46-550bdabfc96b", "f31d2aef-f902-4984-803c-5bdb015e9253" ], "spl_set_id": [ "09566368-f91d-43a3-b683-30c844fb125a", "be1c686e-37a5-4a53-945b-68a6ead35134", "24837d82-0f3f-4482-9af0-31e5f675c30f", "ccb1a15e-c943-4042-ae46-550bdabfc96b", "cb76a73f-549a-4170-b96a-f93ed7e09464" ], "package_ndc": [ "36000-033-10", "63323-660-01", "63323-660-05", "62332-112-30", "62332-112-31", "62332-112-91", "62332-113-30", "62332-113-31", "62332-113-91", "62332-114-30", "62332-114-31", "62332-114-91", "65219-665-01", "65219-665-05", "46708-290-30", "46708-290-31", "46708-290-91", "46708-290-10", "46708-290-71", "46708-291-30", "46708-291-31", "46708-291-91", "46708-291-10", "46708-292-30", "46708-292-31", "46708-292-91", "46708-292-10" ], "unii": [ "W5S57Y3A5L" ] } } ] } } ] }